ClinConnect ClinConnect Logo
Search / Trial NCT06939712

A Study on the Impact of Online Positive Psychological Intervention on the Mental Health and Quality of Life of Crohn's Disease Patients

Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Apr 15, 2025

Trial Information

Current as of July 21, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how an online program designed to boost positive thinking can help improve the mental health and quality of life for people with Crohn's disease. Crohn's disease is a long-lasting condition that causes inflammation in the digestive tract and can lead to both physical and emotional challenges. The researchers believe that by helping patients focus on their positive experiences, they may be able to cope better with stress and improve their overall well-being.

To participate in the study, individuals must be between 18 and 75 years old, diagnosed with Crohn's disease, and experiencing mild to moderate anxiety or depression. They should also be comfortable using the internet and mobile apps. Participants will engage in online training sessions and follow-up procedures as part of the intervention. It’s important to note that individuals with certain psychiatric conditions or other serious health issues may not be eligible for this study. If you or someone you know meets these criteria and is interested, this trial could provide valuable support for managing the emotional aspects of living with Crohn's disease.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients diagnosed with Crohn's disease according to the 2018 diagnostic criteria established by the Inflammatory Bowel Disease Group of the Chinese Medical Association's Gastroenterology Branch;
  • Patients aged between 18 and 75 years;
  • Patients with a score of 5-14 on the GAD-7 (indicative of mild to moderate anxiety) or a score of 5-14 on the PHQ-9 (indicative of mild to moderate depression);
  • Patients who understand and agree to comply with the study requirements and have signed informed consent;
  • Patients who are able to read and access the internet, either independently or with assistance from a family member, and are capable of using WeChat and mobile applications;
  • Patients who are able to complete all course trainings and/or follow-up procedures.
  • Exclusion Criteria:
  • Individuals with a history or current diagnosis of psychiatric illness or cognitive impairment, or those currently taking psychiatric medications; Individuals working in the field of psychology, or those who have previously studied or are currently studying positive psychology;
  • Individuals with concurrent other intestinal diseases or malignancies;
  • Individuals with severe primary diseases of the cardiovascular, cerebrovascular, hepatic, or renal systems.
  • Withdrawal Criteria:
  • Patients lost to follow-up due to withdrawal or other reasons during the intervention period;
  • Patients who develop severe complications or experience significant changes in their condition that prevent them from continuing the study.

About Second Affiliated Hospital, School Of Medicine, Zhejiang University

The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.

Locations

Hangzhou, Zhejiang, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported